Literature DB >> 30289354

Alpha ketoglutarate levels, regulated by p53 and OGDH, determine autophagy and cell fate/apoptosis in response to Nutlin-3a.

Lei Duan1, Ricardo E Perez1, Carl G Maki1.   

Abstract

Activated p53 can promote apoptosis or cell cycle arrest. Differences in energy metabolism can influence cell fate in response to activated p53. Nutlin-3a is a preclinical drug and small molecule activator of p53. Alpha-ketoglutarate (αKG) levels were reduced in cells sensitive to Nutlin-3a-induced apoptosis and increased in cells resistant to this apoptosis. Add-back of a cell-permeable αKG analog (DMKG) rescued cells from apoptosis in response to Nutlin-3a. OGDH is a component of the αKGDH complex that converts αKG to succinate. OGDH knockdown increased endogenous αKG levels and also rescued cells from Nutlin-3a-induced apoptosis. We previously showed reduced autophagy and ATG gene expression contributes to Nutlin-3a-induced apoptosis. DMKG and OGDH knockdown restored autophagy and ATG gene expression in Nutlin-3a-treated cells. These studies indicate αKG levels, regulated by p53 and OGDH, determine autophagy and apoptosis in response to Nutlin-3a.

Entities:  

Keywords:  Alpha-ketoglutarate; Nutlin-3a; apoptosis; autophagy; p53

Year:  2018        PMID: 30289354      PMCID: PMC6370392          DOI: 10.1080/15384047.2018.1523858

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  26 in total

Review 1.  Autophagy, Metabolism, and Cancer.

Authors:  Eileen White; Janice M Mehnert; Chang S Chan
Journal:  Clin Cancer Res       Date:  2015-11-15       Impact factor: 12.531

2.  A versatile tool for conditional gene expression and knockdown.

Authors:  Jolanta Szulc; Maciej Wiznerowicz; Marc-Olivier Sauvain; Didier Trono; Patrick Aebischer
Journal:  Nat Methods       Date:  2006-02       Impact factor: 28.547

3.  Critical roles for nitric oxide and ERK in the completion of prosurvival autophagy in 4OHTAM-treated estrogen receptor-positive breast cancer cells.

Authors:  Lei Duan; Brian Danzer; Victor V Levenson; Carl G Maki
Journal:  Cancer Lett       Date:  2014-07-25       Impact factor: 8.679

4.  mTOR Signaling in Growth, Metabolism, and Disease.

Authors:  Robert A Saxton; David M Sabatini
Journal:  Cell       Date:  2017-04-06       Impact factor: 41.582

5.  Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: targeting Warburg effect to fight cancer.

Authors:  Joanna Zawacka-Pankau; Vera V Grinkevich; Sabine Hünten; Fedor Nikulenkov; Angela Gluch; Hai Li; Martin Enge; Alexander Kel; Galina Selivanova
Journal:  J Biol Chem       Date:  2011-08-23       Impact factor: 5.157

Review 6.  Histone methyl transferases and demethylases; can they link metabolism and transcription?

Authors:  Raffaele Teperino; Kristina Schoonjans; Johan Auwerx
Journal:  Cell Metab       Date:  2010-10-06       Impact factor: 27.287

Review 7.  Another fork in the road--life or death decisions by the tumour suppressor p53.

Authors:  Luis A Carvajal; James J Manfredi
Journal:  EMBO Rep       Date:  2013-04-16       Impact factor: 8.807

8.  The metabolite α-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR.

Authors:  Randall M Chin; Xudong Fu; Melody Y Pai; Laurent Vergnes; Heejun Hwang; Gang Deng; Simon Diep; Brett Lomenick; Vijaykumar S Meli; Gabriela C Monsalve; Eileen Hu; Stephen A Whelan; Jennifer X Wang; Gwanghyun Jung; Gregory M Solis; Farbod Fazlollahi; Chitrada Kaweeteerawat; Austin Quach; Mahta Nili; Abby S Krall; Hilary A Godwin; Helena R Chang; Kym F Faull; Feng Guo; Meisheng Jiang; Sunia A Trauger; Alan Saghatelian; Daniel Braas; Heather R Christofk; Catherine F Clarke; Michael A Teitell; Michael Petrascheck; Karen Reue; Michael E Jung; Alison R Frand; Jing Huang
Journal:  Nature       Date:  2014-05-14       Impact factor: 49.962

9.  Acquisition of p53 mutations in response to the non-genotoxic p53 activator Nutlin-3.

Authors:  M H Aziz; H Shen; C G Maki
Journal:  Oncogene       Date:  2011-06-06       Impact factor: 9.867

10.  p53-regulated autophagy is controlled by glycolysis and determines cell fate.

Authors:  Lei Duan; Ricardo E Perez; Batzaya Davaadelger; Elena N Dedkova; Lothar A Blatter; Carl G Maki
Journal:  Oncotarget       Date:  2015-09-15
View more
  5 in total

1.  The histone demethylase JMJD2B is critical for p53-mediated autophagy and survival in Nutlin-treated cancer cells.

Authors:  Lei Duan; Ricardo E Perez; Xin Lai; Ling Chen; Carl G Maki
Journal:  J Biol Chem       Date:  2019-04-29       Impact factor: 5.157

Review 2.  Targeting 2-oxoglutarate dehydrogenase for cancer treatment.

Authors:  Ling-Chu Chang; Shih-Kai Chiang; Shuen-Ei Chen; Mien-Chie Hung
Journal:  Am J Cancer Res       Date:  2022-04-15       Impact factor: 5.942

3.  Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair.

Authors:  Tsung-Chih Chen; Chi-Yuan Yao; Yu-Ren Chen; Chang-Tsu Yuan; Chien-Chin Lin; Yueh-Chwen Hsu; Po-Han Chuang; Chein-Jun Kao; Yi-Hung Li; Hsin-An Hou; Wen-Chien Chou; Hwei-Fang Tien
Journal:  Oncogene       Date:  2022-01-28       Impact factor: 8.756

Review 4.  Resistance mechanisms to inhibitors of p53-MDM2 interactions in cancer therapy: can we overcome them?

Authors:  Lucia Haronikova; Ondrej Bonczek; Pavlina Zatloukalova; Filip Kokas-Zavadil; Martina Kucerikova; Philip J Coates; Robin Fahraeus; Borivoj Vojtesek
Journal:  Cell Mol Biol Lett       Date:  2021-12-15       Impact factor: 5.787

5.  The mechanism and role of intracellular α-ketoglutarate reduction in hepatic stellate cell activation.

Authors:  Jianjian Zhao; Yueping Jiang; Xueguo Sun; Xishuang Liu; Fuguo Liu; Mingquan Song; Lingyun Zhang
Journal:  Biosci Rep       Date:  2020-03-27       Impact factor: 3.976

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.